Prostacyclin analogs and PDE 5 inhibitors synergistically stimulate ATP release from human RBCs
Prostacyclin (PGI2) and phosphodiesterase 5 (PDE5) inhibitors are vasodilators used in the treatment of pulmonary arterial hypertension (PAH). Althoug...
Source: http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/~3/opD6h2kMI2w/130920143730.htm
No comments:
Post a Comment